Myleofibrosis: Difference between revisions
Jump to navigation
Jump to search
| Line 28: | Line 28: | ||
==Treatment== | ==Treatment== | ||
[[Myleofibrosis medical therapy|Medical Therapy]] | [[Myleofibrosis surgery|Surgery]] | [[Myleofibrosis primary prevention|Primary Prevention]] | [[Myleofibrosis secondary prevention|Secondary Prevention]] | [[Myleofibrosis cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[ | [[Myleofibrosis medical therapy|Medical Therapy]] | [[Myleofibrosis surgery|Surgery]] | [[Myleofibrosis primary prevention|Primary Prevention]] | [[Myleofibrosis secondary prevention|Secondary Prevention]] | [[Myleofibrosis cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Myleofibrosis future or investigational therapies|Future or Investigational Therapies]] | ||
==Case Studies== | ==Case Studies== | ||
Latest revision as of 15:39, 21 September 2012
|
Myleofibrosis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Myleofibrosis On the Web |
|
American Roentgen Ray Society Images of Myleofibrosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Myleofibrosis from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination |Laboratory Findings | X Ray | CT | MRI | Ultrasound | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies